Crispr Therapeutics shares owned by Scotia Capital
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Scotia Capital
from 13F filings
Historical chart of Scotia Capital investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Scotia Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Scotia Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $517k | 11k | 46.98 |
| 2024-03-31 | $792k | 12k | 68.16 |
| 2023-12-31 | $694k | 11k | 62.60 |
| 2023-09-30 | $418k | 9.2k | 45.39 |
| 2023-06-30 | $541k | 9.6k | 56.14 |
| 2021-06-30 | $226k | 1.4k | 161.54 |